Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / Elevated PFAS Linked to Changes in Blood Lipids
Translational Science Translational Science News and Research Environmental Mass Spectrometry

Elevated PFAS Linked to Changes in Blood Lipids 

Serum lipid profiling reveals PFAS-linked shifts in triglyceride and membrane lipid species 

03/17/2026 2 min read

Share

A serum lipidomics analysis using multidimensional mass spectrometry has linked elevated concentrations of per- and polyfluoroalkyl substances (PFAS) in human blood to shifts in specific lipid species. 

The study examined 78 human serum samples from two exposure groups: individuals exposed to PFAS-contaminated drinking water and occupationally exposed firefighters. PFAS levels were first quantified in the samples before lipidomic profiling was performed. 

The analytical workflow integrated PFAS exposure measurements with multidimensional lipidomics profiling, allowing the researchers to investigate potential links between contaminant exposure and changes in circulating lipid species. 

Serum samples were grouped according to their combined concentrations of seven PFAS compounds (Σ7 PFAS), with 34 participants exceeding 20 ng mL⁻¹ – a threshold associated with increased risk of dyslipidemia in National Academies exposure guidance. Multidimensional lipidomics analysis using liquid chromatography, ion mobility spectrometry, and collision-induced dissociation mass spectrometry (LC-IMS-CID-MS) detected 387 lipid species spanning five major lipid categories and 15 classes using an in-house reference library of 877 lipids. 

Statistical comparisons between exposure groups identified 25 lipid species that differed significantly between exposure levels, with 24 showing higher abundance in individuals with elevated Σ7 PFAS levels. 

Triglycerides and phosphatidylethanolamines accounted for more than 60 percent of the lipids elevated in the higher-exposure group, suggesting PFAS exposure may influence pathways involved in cellular membrane composition and energy storage. Several triglyceride species – including TG (60:13) – and phosphatidylethanolamines such as PE (18:0_22:6) were among the lipids most strongly associated with PFAS levels. 

Further statistical analysis revealed multiple correlations between individual PFAS compounds and lipid species. In particular, PFNA, PFOA, and PFDA showed numerous positive correlations with triglycerides, sphingomyelins, and other lipid classes, indicating possible links between PFAS exposure and broader lipid metabolic changes. 

The researchers note that differences in age, sex, and occupational factors could influence lipid profiles, and additional studies will be needed to clarify the biological mechanisms underlying the observed associations. 

“Applying both PFAS and lipidomic analyses, in addition to other omics, to future studies will also reveal more information regarding altered biological mechanisms due to PFAS exposure,” they conclude. 

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #5
Translational Science
The Analytical Scientist Innovation Awards 2024: #5

December 4, 2024

4 min read

Welcome to the 5th ranked Innovation, Pyxis – introduced here by Matterworks co-founder Jack Geremia

The Analytical Scientist Innovation Awards 2024: #4
Translational Science
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

The Analytical Scientist Innovation Awards 2024: #3
Translational Science
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

Spit It Out
Translational Science
Spit It Out

December 4, 2024

1 min read

Saliva-based PA-MS test detects paracetamol overdose in just 10 minutes

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.